Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 for Gastritis Research: Study Type Comparison

Acute ethanol ulcer (rodent) Lesion area reduction at 24h Ethanol-induced gastric damage 68% lesion reduction vs saline (10 μg/kg IP) Single-dose, no chronic inflammation model Shows tissue repair capacity but doesn't model chronic gastritis pathology Chronic

This comparison does not assign a generated winner or score.

  • Acute ethanol ulcer (rodent)
  • Lesion area reduction at 24h
  • Ethanol-induced gastric damage
  • 68% lesion reduction vs saline (10 μg/kg IP)
  • Single-dose, no chronic inflammation model
  • Shows tissue repair capacity but doesn't model chronic gastritis pathology
  • Chronic NSAID damage (rodent)
  • Mucosal healing over 14 days
  • Indomethacin daily administration
  • Accelerated epithelial restitution, reduced hemorrhage
  • Discontinued BPC-157 → lesion recurrence
  • Suggests adjunct potential but not standalone long-term solution
  • H. pylori infection (gerbil)
  • Bacterial colonization density
  • Live H. pylori inoculation
  • 42% reduction in colonization, lower inflammatory scores
  • Species difference; mechanism unclear
  • Intriguing antimicrobial signal but needs mechanistic clarification
  • Dose-response analysis
  • Optimal concentration for VEGF upregulation
  • In vitro gastric cell culture
  • Peak VEGF expression at 1–10 μg/mL, plateau above 50 μg/mL
  • No in vivo correlation established
  • Identifies therapeutic window but tissue penetration differs in vivo
More references

Related material